Evidence map›Paper›PMID 39200079›Full record

ArticleAntibiotics (Basel, Switzerland)2024

EDBD-3,6-Epidioxy-1,10-Bisaboladiene-An Endoperoxide Sesquiterpene Obtained from

Eric Umehara, Thainá R Teixeira, Rayssa A Cajás, Monique C Amaro, Josué de Moraes, João Henrique G Lago

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Plant-Derived Terpenes as Emerging Therapeutics Against Schistosomiasis.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Anti-ACS omega · 2025
    Article
  4. Molecules (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eric UmeharaCentro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André 09280-560, SP, Brazil.
Thainá R TeixeiraCentro de Pesquisas de Doenças Negligenciadas, Universidade Guarulhos, Guarulhos 07023-070, SP, Brazil.
Rayssa A CajásCentro de Pesquisas de Doenças Negligenciadas, Universidade Guarulhos, Guarulhos 07023-070, SP, Brazil.
Monique C AmaroCentro de Pesquisas de Doenças Negligenciadas, Universidade Guarulhos, Guarulhos 07023-070, SP, Brazil.
Josué de MoraesCentro de Pesquisas de Doenças Negligenciadas, Universidade Guarulhos, Guarulhos 07023-070, SP, Brazil.ORCID 0000-0003-1766-7031
João Henrique G LagoCentro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André 09280-560, SP, Brazil.ORCID 0000-0002-1193-8374

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico Investigator FellowshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior Finance Code 001Fundação de Amparo à Pesquisa do Estado de São Paulo 23/08418-6 and 23/12447-1
6 · The paper itself

Abstract

Schistosomiasis, a neglected tropical disease impacting over 250 million individuals globally, remains a major public health challenge due to its prevalence and significant impact on affected communities. Praziquantel, the sole available treatment, highlights the urgency of the need for novel anthelmintic agents to achieve the World Health Organization (WHO) goal of schistosomiasis elimination. Previous studies reported the promising antiparasitic activity of different terpenoids against

Indexed as

3,6-epidioxy-1,10-bisaboladieneantiparasitic propertiesantischistosomal activityDrimys brasiliensisschistosomiasis

Identifiers

PMID39200079
PMCPMC11350924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.